Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)

Conditions: Hepatocellular Carcinoma Interventions: Drug: INCB099280 Sponsors: Abramson Cancer Center at Penn Medicine; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials